1. Inhibition of autophagy enhances the radiosensitivity of nasopharyngeal carcinoma by reducing Rad51 expression
    NING MO et al, 2014 CrossRef
  2. Targeting the NF-E2-related factor 2 pathway: A novel strategy for glioblastoma (Review)
    JIANHONG ZHU et al, 2014 CrossRef
  3. Upregulation of CASC2 sensitized glioma to temozolomide cytotoxicity through autophagy inhibition by sponging miR-193a-5p and regulating mTOR expression.
    Chunming Jiang et al, 2018, Biomed Pharmacother CrossRef
  4. FTY720 inhibits the Nrf2/ARE pathway in human glioblastoma cell lines and sensitizes glioblastoma cells to temozolomide
    Li Zhang et al, 2017, Pharmacological Reports CrossRef
  5. VPA and MEL induce apoptosis by inhibiting the Nrf2-ARE signaling pathway in TMZ-resistant U251 cells
    Hao Pan et al, 2017 CrossRef
  6. Differential Nrf2 expression between glioma stem cells and non-stem-like cells in glioblastoma.
    Jianhong Zhu et al, 2014, Oncol Lett CrossRef
  7. Targeting Nrf-2 is a promising intervention approach for the prevention of ethanol-induced liver disease
    Ning Zhao et al, 2018, Cell. Mol. Life Sci. CrossRef
  8. Expression of the Nrf2 and Keap1 proteins and their clinical significance in osteosarcoma
    Jihong Zhang et al, 2016, Biochemical and Biophysical Research Communications CrossRef
  9. Nrf2-Keap1 pathway promotes cell proliferation and diminishes ferroptosis.
    Z Fan et al, 2017, Oncogenesis CrossRef
  10. MicroRNA-141 protects PC12 cells against hypoxia/reoxygenation-induced injury via regulating Keap1-Nrf2 signaling pathway
    Bin Zhou et al, 2019, J Bioenerg Biomembr CrossRef
  11. Nrf2 and Nrf1 signaling and ER stress crosstalk: implication for proteasomal degradation and autophagy
    Hadi Digaleh et al, 2013, Cell. Mol. Life Sci. CrossRef
  12. Nrf2 is required to maintain the self-renewal of glioma stem cells
    Jianhong Zhu et al, 2013, BMC Cancer CrossRef
  13. tert-Butylhydroquinone (tBHQ) protects hepatocytes against lipotoxicity via inducing autophagy independently of Nrf2 activation
    Songtao Li et al, 2014, Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids CrossRef
  14. Temozolomide and irradiation combined treatment-induced Nrf2 activation increases chemoradiation sensitivity in human glioblastoma cells
    Zi-Xiang Cong et al, 2014, J Neurooncol CrossRef
  15. Knockdown of Nrf2 suppresses glioblastoma angiogenesis by inhibiting hypoxia-induced activation of HIF-1α.
    Xiangjun Ji et al, 2014, Int J Cancer CrossRef
  16. The effect of transforming growth factor β1 on the crosstalk between autophagy and apoptosis in the annulus fibrosus cells under serum deprivation
    Bin-Bin Ni et al, 2014, Cytokine CrossRef
  17. Targeting Notch Signaling and Autophagy Increases Cytotoxicity in Glioblastoma Neurospheres
    Manabu Natsumeda et al, 2016, Brain Pathology CrossRef
  18. Downregulation of Nrf2 by the combination of TRAIL and Valproic acid induces apoptotic cell death of TRAIL-resistant papillary thyroid cancer cells via suppression of Bcl-xL
    Hyun-Young Cha et al, 2016, Cancer Letters CrossRef
  19. Therapeutic strategies of drug repositioning targeting autophagy to induce cancer cell death: from pathophysiology to treatment.
    Go J Yoshida, 0 CrossRef
  20. Targeting the Sphingolipid System as a Therapeutic Direction for Glioblastoma
    Melinda N. Tea et al, 2020, Cancers CrossRef
  21. Melatonin’s Antineoplastic Potential Against Glioblastoma
    Enrico Moretti et al, 2020, Cells CrossRef
  22. NRF2 and glutathione are key resistance mediators to temozolomide in glioma and melanoma cells
    Clarissa Ribeiro Reily Rocha et al, 2016, Oncotarget CrossRef
  23. Targeting NRF2, Regulator of Antioxidant System, to Sensitize Glioblastoma Neurosphere Cells to Radiation-Induced Oxidative Stress.
    Elza Sakamoto-hojo, 0 CrossRef
  24. MicroRNA‑30a increases the chemosensitivity of U251 glioblastoma cells to temozolomide by directly targeting beclin�1 and inhibiting autophagy
    Jing Xu et al, 2018, Exp Ther Med CrossRef
  25. Drug Resistance in Glioblastoma: The Two Faces of Oxidative Stress
    Christophe Olivier et al, 2021, Front. Mol. Biosci. CrossRef
  26. Activation of Nrf2/ HO ‐1 signaling pathway attenuates ROS ‐mediated autophagy induced by silica nanoparticles in H9c2 cells
    Guanqun Cui et al, 2021, Environmental Toxicology CrossRef
  27. Overexpression of Nrf2 attenuates Carmustine-induced cytotoxicity in U87MG human glioma cells
    Sangeetha Sukumari-Ramesh et al, 2015, BMC Cancer CrossRef
  28. Influence of N-alkynylaminosteroids on mitochondria function and autophagy in glioma cells
    J.U. Panada et al, 2022, BIOMED KHIM CrossRef
  29. Alterations in Molecular Profiles Affecting Glioblastoma Resistance to Radiochemotherapy: Where Does the Good Go?
    Juliana B. Vilar et al, 2022, Cancers CrossRef
  30. The Role of NRF2/KEAP1 Pathway in Glioblastoma: Pharmacological Implications
    Seyed Hossein Shahcheraghi et al, 2022, Med Oncol CrossRef
  31. Normal and Pathological NRF2 Signalling in the Central Nervous System
    Tony Heurtaux et al, 2022, Antioxidants CrossRef
  32. Influence of N-Alkynylaminosteroids on Mitochondrial Functioning and Autophagy in Glioma Cells
    J. U. Panada et al, 2022, Biochem. Moscow Suppl. Ser. B CrossRef
  33. Nrf2 and Moirai: Life and Death Decisions on Cell Fates
    Yoko Yagishita et al, 2022, Antioxidants & Redox Signaling CrossRef
  34. A New Nrf2 Inhibitor Enhances Chemotherapeutic Effects in Glioblastoma Cells Carrying p53 Mutations
    Rayhaneh Afjei et al, 2022, Cancers CrossRef
  35. Temozolomide Resistance in Glioblastoma by NRF2: Protecting the Evil
    Karoline Almeida Lima et al, 2023, Biomedicines CrossRef
  36. The molecular mechanisms of drug resistance of glioblastoma: differentiation and apoptosis
    A. N. Chernov et al, 2024, jour CrossRef